Compare WTFC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTFC | ICLR |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | Ireland |
| Employees | 5902 | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 8.2B |
| IPO Year | N/A | 2001 |
| Metric | WTFC | ICLR |
|---|---|---|
| Price | $145.96 | $116.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $163.87 | ★ $178.62 |
| AVG Volume (30 Days) | 352.9K | ★ 745.0K |
| Earning Date | 04-20-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.77 | N/A |
| Revenue Next Year | $6.32 | N/A |
| P/E Ratio | $13.60 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $100.37 | $66.57 |
| 52 Week High | $162.96 | $211.00 |
| Indicator | WTFC | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 60.33 | 59.85 |
| Support Level | $140.51 | $95.75 |
| Resistance Level | $149.79 | $155.58 |
| Average True Range (ATR) | 2.71 | 4.89 |
| MACD | 1.42 | 1.86 |
| Stochastic Oscillator | 89.90 | 96.77 |
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. Its operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.